ATE497389T1 - Aus stammzellen erhaltener parakriner faktor h12 zur verwendung für die verringerung zelltodes oder für die reparatur von gewebe - Google Patents
Aus stammzellen erhaltener parakriner faktor h12 zur verwendung für die verringerung zelltodes oder für die reparatur von gewebeInfo
- Publication number
- ATE497389T1 ATE497389T1 AT06802032T AT06802032T ATE497389T1 AT E497389 T1 ATE497389 T1 AT E497389T1 AT 06802032 T AT06802032 T AT 06802032T AT 06802032 T AT06802032 T AT 06802032T AT E497389 T1 ATE497389 T1 AT E497389T1
- Authority
- AT
- Austria
- Prior art keywords
- cell death
- factor
- tissue
- paraccrine
- repair
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Marine Sciences & Fisheries (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71002805P | 2005-08-19 | 2005-08-19 | |
US71128705P | 2005-08-25 | 2005-08-25 | |
PCT/US2006/032656 WO2007022515A2 (en) | 2005-08-19 | 2006-08-21 | Stem cell derived factors for treating pathologic conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE497389T1 true ATE497389T1 (de) | 2011-02-15 |
Family
ID=37758496
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06802032T ATE497389T1 (de) | 2005-08-19 | 2006-08-21 | Aus stammzellen erhaltener parakriner faktor h12 zur verwendung für die verringerung zelltodes oder für die reparatur von gewebe |
AT08005943T ATE499110T1 (de) | 2005-08-19 | 2006-08-21 | Aus stammzellen erhaltener parakriner faktor sfrp1 zur verwendung für die verringerung zelltodes im herzgewebe |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08005943T ATE499110T1 (de) | 2005-08-19 | 2006-08-21 | Aus stammzellen erhaltener parakriner faktor sfrp1 zur verwendung für die verringerung zelltodes im herzgewebe |
Country Status (6)
Country | Link |
---|---|
US (6) | US7638128B2 (de) |
EP (4) | EP1977758B1 (de) |
AT (2) | ATE497389T1 (de) |
CA (2) | CA2619593C (de) |
DE (2) | DE602006019974D1 (de) |
WO (1) | WO2007022515A2 (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7893018B2 (en) * | 2005-11-08 | 2011-02-22 | Foundation For Biomedical Research And Innovation | Method of treatment for ischemic heart disease |
GB0707348D0 (en) * | 2007-04-17 | 2007-05-23 | Renovo Ltd | Medicaments and methods for inhibition of scarring |
US20110071086A1 (en) * | 2007-11-04 | 2011-03-24 | Dzau Victor J | Compositions for tissue repair/regeneration |
US20120156134A1 (en) | 2007-12-20 | 2012-06-21 | Shayne Squires | Compositions and methods for detecting or eliminating senescent cells to diagnose or treat disease |
CN102027374A (zh) | 2008-04-30 | 2011-04-20 | 霍夫曼-拉罗奇有限公司 | Sfrp-3在评价心力衰竭中的用途 |
GB0818725D0 (en) | 2008-10-13 | 2008-11-19 | Habib Nagy A | Pharmaceutical composition |
CA2755396A1 (en) * | 2009-03-13 | 2010-09-16 | Duke University | Use of hasf as a protective agent against ischemic tissue damage |
US20120107413A1 (en) * | 2009-07-23 | 2012-05-03 | Singapore Health Services Pte Ltd | Pre-natal mesenchymal stem cells |
JP5409222B2 (ja) * | 2009-09-10 | 2014-02-05 | 学校法人慶應義塾 | 造血幹細胞の培養方法 |
WO2012175745A1 (en) * | 2011-06-24 | 2012-12-27 | National University Of Ireland, Galway | Cell secreted proteins for the treatment of myocardial infarction |
US9950032B2 (en) * | 2011-10-27 | 2018-04-24 | Agency For Science, Technology And Research (A*Star) | Compositions and methods for lung regeneration |
ES2869701T3 (es) | 2012-08-01 | 2021-10-25 | United Therapeutics Corp | Tratamiento de hipertensión arterial pulmonar con células progenitoras endoteliales tratadas con prostaciclina |
EP2879682B1 (de) | 2012-08-01 | 2018-03-21 | United Therapeutics Corporation | Behandlung von pulmonal-arteriellem hochdruck mit mesenchymalen stammzellen |
US10080730B2 (en) * | 2013-01-09 | 2018-09-25 | United Therapeutics Corporation | Treatment of vasculopathy with prostacyclin and mesenchymal stem cells |
CN105561338A (zh) * | 2015-05-14 | 2016-05-11 | 首都医科大学附属北京口腔医院 | Sfrp2在促进牙源性间充质干细胞成骨/成牙分化中的应用 |
WO2018064315A1 (en) * | 2016-09-29 | 2018-04-05 | North Carolina State University | Stem cell biomimetic microparticles |
AU2017350732B2 (en) | 2016-10-24 | 2023-07-27 | United Therapeutics Corporation | Enhancement of MSC immunomodulatory properties by treprostinil |
WO2022066714A2 (en) * | 2020-09-22 | 2022-03-31 | Children's Medical Center Corporation | Delivery of sfrp-3 or foxm1 inhibitor to protect from and treat mitral regurgitation and heart failure |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE318915T1 (de) * | 1996-09-24 | 2006-03-15 | Tanox Inc | Genfamilie von apoptose-verwandten peptiden, dadurch kodierte peptide und verfahren zu deren herstellung |
CA2331386A1 (en) * | 1998-06-26 | 2000-01-06 | Incyte Pharmaceuticals, Inc. | Human signal peptide-containing proteins |
US20030027751A1 (en) * | 2001-04-10 | 2003-02-06 | Genvec, Inc. | VEGF fusion proteins |
WO2003080795A2 (en) * | 2001-08-09 | 2003-10-02 | Nuvelo Inc. | Novel nucleic acids and secreted polypeptides |
WO2003062376A2 (en) * | 2002-01-16 | 2003-07-31 | Incyte Genomics, Inc. | Molecules for diagnostics and therapeutics |
US20040258669A1 (en) * | 2002-11-05 | 2004-12-23 | Dzau Victor J. | Mesenchymal stem cells and methods of use thereof |
JP2006508682A (ja) * | 2002-12-06 | 2006-03-16 | ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ | β−カテニンシグナル伝達経路の調節による細胞傷害剤からの幹細胞の保護 |
WO2004087874A2 (en) * | 2003-03-28 | 2004-10-14 | Nuvelo, Inc. | Novel nucleic acids and polypeptides |
-
2006
- 2006-08-21 DE DE602006019974T patent/DE602006019974D1/de active Active
- 2006-08-21 AT AT06802032T patent/ATE497389T1/de not_active IP Right Cessation
- 2006-08-21 CA CA2619593A patent/CA2619593C/en not_active Expired - Fee Related
- 2006-08-21 EP EP08005943A patent/EP1977758B1/de not_active Not-in-force
- 2006-08-21 WO PCT/US2006/032656 patent/WO2007022515A2/en active Application Filing
- 2006-08-21 AT AT08005943T patent/ATE499110T1/de not_active IP Right Cessation
- 2006-08-21 EP EP06802032A patent/EP1940445B1/de not_active Not-in-force
- 2006-08-21 CA CA3022238A patent/CA3022238A1/en not_active Abandoned
- 2006-08-21 EP EP10164374A patent/EP2226079B1/de not_active Not-in-force
- 2006-08-21 EP EP12175811.4A patent/EP2548569B1/de not_active Not-in-force
- 2006-08-21 DE DE602006020349T patent/DE602006020349D1/de active Active
- 2006-08-21 US US11/508,010 patent/US7638128B2/en active Active - Reinstated
-
2008
- 2008-01-11 US US12/008,583 patent/US8129344B2/en active Active
-
2010
- 2010-03-18 US US12/726,468 patent/US8703710B2/en active Active - Reinstated
-
2014
- 2014-04-18 US US14/256,169 patent/US9279012B2/en active Active
- 2014-04-18 US US14/256,174 patent/US9353168B2/en active Active
-
2016
- 2016-05-27 US US15/167,058 patent/US20170128526A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1940445B1 (de) | 2011-02-02 |
EP1940445A4 (de) | 2008-10-15 |
US20140357703A1 (en) | 2014-12-04 |
CA2619593A1 (en) | 2007-02-22 |
US20140296152A1 (en) | 2014-10-02 |
CA2619593C (en) | 2018-12-11 |
CA3022238A1 (en) | 2007-02-22 |
US20070259425A1 (en) | 2007-11-08 |
US7638128B2 (en) | 2009-12-29 |
EP1977758A3 (de) | 2009-01-07 |
EP1977758A2 (de) | 2008-10-08 |
EP2226079A3 (de) | 2010-12-08 |
WO2007022515A9 (en) | 2007-05-10 |
WO2007022515A3 (en) | 2008-02-28 |
US8129344B2 (en) | 2012-03-06 |
US9279012B2 (en) | 2016-03-08 |
US20170128526A1 (en) | 2017-05-11 |
US20120283183A9 (en) | 2012-11-08 |
US20110003743A1 (en) | 2011-01-06 |
EP1977758B1 (de) | 2011-02-23 |
WO2007022515A2 (en) | 2007-02-22 |
EP2226079B1 (de) | 2012-07-11 |
EP1940445A2 (de) | 2008-07-09 |
EP2548569B1 (de) | 2014-01-29 |
EP2226079A2 (de) | 2010-09-08 |
DE602006019974D1 (de) | 2011-03-17 |
US8703710B2 (en) | 2014-04-22 |
ATE499110T1 (de) | 2011-03-15 |
US9353168B2 (en) | 2016-05-31 |
US20080176207A1 (en) | 2008-07-24 |
EP2548569A1 (de) | 2013-01-23 |
DE602006020349D1 (de) | 2011-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE497389T1 (de) | Aus stammzellen erhaltener parakriner faktor h12 zur verwendung für die verringerung zelltodes oder für die reparatur von gewebe | |
DE60228460D1 (de) | Verfahren zur Herstellung und Reinigung von Erythropoietin | |
ATE470702T1 (de) | Verfahren zur herstellung von permanenten humanen zelllinien | |
ATE518496T1 (de) | Verfahren zur gewinnung von lebensfähigen kleinen gewebeteilchen und ihre verwendung für die gewebereparatur | |
EP2342333A4 (de) | Verfahren zur herstellung induzierter pluripotenter stammzellen | |
ATE513788T1 (de) | Verfahren zur reinigung von lithiumsulfid | |
DE602005023332D1 (de) | Kollagenproduzierende pflanzen sowie verfahren zu deren erzeugung und verwendung | |
EA200401591A1 (ru) | Керамические аноды и способ их изготовления | |
WO2006017134A3 (en) | Preprimitive streak and mesendoderm cells | |
BR122019022434B8 (pt) | método para cultivar células de mamífero que secretam proteína heteróloga em um sobrenadante de cultura celular | |
NZ569543A (en) | Means and methods for influencing the stability of antibody producing cells | |
BRPI0511318B8 (pt) | processo para a produção de 4-(benzimidazol-2-ilmetilamino)-benzamidinas, bem como produtos intermediários | |
IL189193A (en) | Transplastic plants expressing a space-oriented protein | |
DE602006018634D1 (de) | Transformierte Hefezellen UND VERFAHREN ZUR HERSTELLUNG VON FREMDPROTEIN | |
AR063972A1 (es) | Plantas con rasgos mejorados relacionados con el rendimiento y un metodo para producirlas | |
DE602005002829D1 (de) | Verwendung eines serumfreien zellkulturmediums zur produktion von il-18bp in säugerzellen | |
TW200736399A (en) | Expansion and differentiation of neural stem cells under low oxygen conditions | |
ATE449608T1 (de) | Verwendung von cxcl6 chemokin bei der prävention oder reparatur von knorpeldefekten | |
ATE523579T1 (de) | Verfahren zur herstellung von brea aus teer und durch oxidative thermische behanlung von kohleteer erhaltenen destillaten davon | |
DE602006017223D1 (de) | Biologische materialien und verwendungen davon | |
WO2011005974A3 (en) | Interpenetrating biomaterial matrices and uses thereof | |
FR2944716B1 (fr) | Catalyseur et procede d'oxydation electrochimique du methane | |
ATE541045T1 (de) | Enzymatisches verfahren zur herstellung bioaktiver, osteoblasten-stimulierender oberflachen und verwendung derselben | |
CR11725A (es) | Método para la producción de una enzima lisosomal recombinante humana en endoesperma de cereal | |
WO2010138873A8 (en) | Long term expansion of human hematopoietic stem cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |